Skip to main content
EYPT logo

EyePoint, Inc.

EYPTNASDAQHealthcareBiotechnology

$2.99Today:- (-)1Y −73.00%

As of Oct 16, 2026 close

Market cap
$271.75M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.93$19.11
Volume (live)
-
Avg. volume (3M)
3.20M

EyePoint (EYPT) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), EyePoint used $240.11M of cash in operating activities and spent $3.28M on capital expenditures. That left free cash flow of −$243.39M. It repurchased $1.39M of its own shares.

EyePoint Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for EyePoint, Inc. (EYPT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Jun 2018Jun 2017
Operating Activities
Net Income-231.96-130.87-70.80-102.25-58.42-45.39-56.79-53.17-18.49
Depreciation & Amortization2.311.540.462.452.772.652.601.150.82
Deferred Income Tax0.280.090.080.00-0.790.913.8126.280.00
Stock Based Compensation27.8736.7412.0614.187.455.554.573.972.46
Change in Working Capital-33.78-27.7758.88-3.02-1.7420.14-12.54-0.940.25
Change in Accounts Receivable-10.67-0.2414.43-2.66-10.604.85-15.30-0.060.22
Change in Inventory0.491.60-1.55-0.761.35-3.20-1.86-0.280.00
Change in Accounts Payable4.685.731.521.208.481.874.60-0.30-0.35
Change in Other Working Capital-4.83-5.9544.48-0.56-0.030.070.03-0.300.38
Other Operating Activities-4.83-5.951.18-0.56-0.161.881.650.81-5.52
Net Cash from Operating Activities-240.11-126.231.88-65.01-50.10-14.44-56.70-21.91-20.49
Investing Activities
Capital Expenditures-3.28-4.05-3.48-2.15-0.16-0.36-0.21-0.11-0.15
Acquisitions0.160.00-0.17-0.560.000.000.00-16.78-16.78
Purchases of Investments-252.02-398.30-55.12-139.12-32.970.000.000.000.00
Sales/Maturities of Investments323.73183.0055.28124.000.000.000.000.000.00
Other Investing Activities4.835.950.170.560.000.000.000.000.00
Net Cash from Investing Activities68.58-219.36-3.32-17.27-33.12-0.36-0.21-16.89-16.89
Financing Activities
Debt Repayment-0.11-0.11-40.51-71.77-0.15-13.8430.0020.0020.00
Common Stock Issued173.45163.31226.170.40217.2050.2123.0429.4041.52
Common Stock Repurchased-1.390.000.000.00-0.15-0.09-0.130.000.00
Other Financing Activities-1.93-5.181.41-3.19-0.15-0.83-19.05-20.20-53.01
Net Cash from Financing Activities173.65164.02187.07-0.69216.9037.4933.8629.208.50
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.000.000.00
Net Change in Cash2.12-181.56185.63-82.96133.6822.70-23.0521.881.59
Cash at Beginning of Period99.85281.4195.63178.7445.0622.3645.4117.0515.31
Cash at End of Period101.9799.85281.2695.78178.7445.0622.3638.9316.90
Free Cash Flow-243.39-130.28-1.61-67.16-50.25-14.80-56.91-22.02-20.64
Supplemental Disclosures
Interest Paid--1.412.604.855.51---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About EyePoint Cash Flow

What is EyePoint's free cash flow?

EyePoint had negative free cash flow of $243.39M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$240.11M minus $3.28M of capital expenditures.

How much does EyePoint spend on capital expenditures?

EyePoint spent $3.28M on capital expenditures in fiscal 2025, compared with $4.05M a year earlier.

Does EyePoint pay dividends or buy back shares?

Yes. In fiscal 2025 EyePoint returned $1.39M in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition